Evidence map›Paper›PMID 29440413›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70

Maria Letizia Giardino Torchia, Debjani Dutta, Paul R Mittelstadt, June Guha, Matthias M Gaida, Kamonwan Fish, Valarie A Barr, Itoro O Akpan, Lawrence E Samelson, Harichandra D Tagad and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Role of Atypical MAPK p38 Signaling in the Progression of Influenza A-Induced Acute Lung Injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Gadd45 Proteins in Immunity 2.0.Advances in experimental medicine and biology · 2022
    Article
  12. T cell receptor (TCR) signaling in health and disease.Signal transduction and targeted therapy · 2021
    Review
  13. Article
  14. Review
  15. Atypical p38 Signaling, Activation, and Implications for Disease.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Maria Letizia Giardino TorchiaLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Debjani DuttaLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Paul R MittelstadtLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
June GuhaLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Matthias M GaidaLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Kamonwan FishLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Valarie A BarrLaboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Itoro O AkpanLaboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Lawrence E SamelsonLaboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Harichandra D TagadLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Subrata DebnathLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Lisa M Miller JenkinsLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Ettore AppellaLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Jonathan D AshwellLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; jda@pop.nci.nih.gov.ORCID 0000-0002-7386-8738
National Institutes of Health · US

Funding

Regulation and Function of WIP1 Phosphatase and its Role in Tumor CellsZIABC011197 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI APPELLA, ETTORE · 2009 to 2025
$11.5M
T cell receptor proximal signalingZIABC011715 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ASHWELL, JONATHAN · 2016 to 2024
$4.7M
6 · The paper itself

Abstract

ZAP-70 is a tyrosine kinase that is essential for initiation of T cell antigen receptor (TCR) signaling. We have found that T cell p38 MAP kinase (MAPK), which is directly phosphorylated and activated by ZAP-70 downstream of the TCR, in turn phosphorylates Thr-293 in the interdomain B region of ZAP-70. Mutant T cells expressing ZAP-70 with an alanine substitution at this residue (ZAP-70

Indexed as

Amino Acid SequenceGene Expression RegulationGenes, T-Cell ReceptorHumansJurkat Cellsp38 Mitogen-Activated Protein KinasesPhosphorylationSignal TransductionZAP-70 Protein-Tyrosine Kinasep38 Mitogen-Activated Protein KinasesZAP70 protein, humanZAP-70 Protein-Tyrosine Kinaseimmune synapseMAP kinasesignal transductionT cell antigen receptor

Identifiers

PMID29440413
PMCPMC5834678
OpenAlexW2792083290

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.